TARGETGENE BIOTECHNOLOGIES LTD has a total of 17 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2012. It filed its patents most often in United States, Australia and Brazil. Its main competitors in its focus markets biotechnology and pharmaceuticals are CHECKMATE PHARMACEUTICALS INC, NOUSCOM AG and AVIDITY BIOSCIENCES LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | Australia | 2 | |
#3 | Brazil | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Hong Kong | 1 | |
#8 | Israel | 1 | |
#9 | India | 1 | |
#10 | New Zealand | 1 | |
#11 | Philippines | 1 | |
#12 | Ukraine | 1 | |
#13 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Shiboleth Yoel Moshe | 14 |
#2 | Weinthal Dan Michael | 13 |
#3 | Yoel Moshe Shiboleth | 2 |
#4 | Dan Michael Weinthal | 2 |
#5 | Weintal Dan Michael | 1 |
#6 | Moshe Shiboleth Yoel | 1 |
#7 | Michael Weinthal Dan | 1 |
Publication | Filing date | Title |
---|---|---|
IL232832D0 | Compositions and methods for modifying a predetermined target nucleic acid sequence | |
US2015211023A1 | Compositions and Methods for Modifying a Predetermined Target Nucleic Acid Sequence |